Pharma megadeals do nothing for neglected medicines
Drug giants are busy gobbling each other up to consolidate their strengths. What does this mean for the health challenges already on their fringes?
US death penalty practices raise disturbing questions
A botched execution, drawn-out court battles and fresh concerns over the innocence of those on death row are plaguing the nation's capital punishment programmes
Scent of a man: Male sweat stresses out lab mice
Mice and rats get more stressed by male experimenters than females – which may explain why it is hard to replicate biomedical animal studies
Tilting smartwatch cuts need for fiddly screen-jabbing
Tapping and swiping on smartwatch apps obstructs the little screen – a watch that detects tilts like a games controller might make them easier to use
Nested interests: A bespoke farm for edible bird nests
With the market for bird's nest soup at $5 billion a year, the natural supply is not meeting demand, so farmers are offering swiftlets good nesting spots
Weird thought-generator: How society's fears shape OCD
From ideas of murder to irrational fears, intrusive thoughts afflict most people. But when David Adam's fear of catching HIV persisted, he developed OCD
Safety fears spook New Zealand's drug reform pioneers
A radical new approach to recreational drugs pursued by New Zealand may be stumbling at the first hurdle, as politicians cancel the first phase of the programme
Watson in your pocket: Supercomputer gets own apps
Watson, the cognitive computer that can be an expert in any subject is moving to the cloud, and will soon be accessible via smartphone app
Insulin-making cells created by Dolly-cloning method
Skin cells from a woman with diabetes have been turned into insulin-producing cells, via a cloning technique similar to the one that made Dolly the sheep
If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.
